Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2026-03-01 @ 9:54 PM
Study NCT ID:
NCT05951205
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-07-02
First Post:
2023-06-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of Efficacy and Safety of a Single Dose of Exa-cel in Participants With Severe Sickle Cell Disease, βS/βC Genotype
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2027-07-31
Start Date Type:
ESTIMATED
Primary Completion Date:
2033-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2033-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-06-23
First Submit QC Date:
None
Study First Post Date:
2023-07-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-27
Last Update Post Date:
2025-07-02
Last Update Post Date Type:
ACTUAL